Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 32.36% is in line with its 5-year average of 31.94%, around the middle of its 5-year range (30.94%–34.15%).
0.13% below its 12-month average of 32.40%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 32.21%.
GROSS MARGIN
32.36%
GROSS MARGIN AVG TTM
32.40%
GROSS MARGIN AVG 3Y
32.23%
GROSS MARGIN AVG 5Y
31.94%
GROSS MARGIN AVG 10Y
29.91%
GROSS MARGIN AVG 15Y
29.06%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.13%
CURRENT VS 3Y AVG
+0.41%
CURRENT VS 5Y AVG
+1.31%
CURRENT VS 10Y AVG
+8.19%
CURRENT VS 15Y AVG
+11.34%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
-19.74%
vs the sector median at left
Addus HomeCare Corporation
Market Cap
$2.11B
Gross Margin
32.36%
TTM Avg
32.40%
3Y Avg
32.23%
5Y Avg
31.94%
Market Cap
$2.11B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
22.50%
5Y Avg
47.90%
Market Cap
$2.06B
Gross Margin
100.00%
TTM Avg
-1064.88%
3Y Avg
-1783.56%
5Y Avg
-1442.31%
Market Cap
$2.04B
Gross Margin
97.82%
TTM Avg
97.53%
3Y Avg
97.80%
5Y Avg
96.20%
Market Cap
$2.06B
Gross Margin
17.11%
TTM Avg
17.72%
3Y Avg
20.44%
5Y Avg
20.08%
Market Cap
$2.02B
Gross Margin
90.36%
TTM Avg
88.22%
3Y Avg
91.04%
5Y Avg
93.63%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Addus HomeCare Corporation (ADUS) | $2.11B | 32.36% | 32.40% | 32.23% | 31.94% |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 0.00% | 0.00% | 22.50% | 47.90% |
| Pharvaris N.V. (PHVS)vs › | $2.15B | 0.00% | 0.00% | 0.00% | 0.00% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 100.00% | -1064.88% | -1783.56% | -1442.31% |
| Alvotech (ALVO)vs › | $2.06B | 60.45% | 60.99% | 17.21% | 44.81% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 97.82% | 97.53% | 97.80% | 96.20% |
| Progyny, Inc. (PGNY)vs › | $2.04B | 24.57% | 22.67% | 22.13% | 21.88% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.06B | 17.11% | 17.72% | 20.44% | 20.08% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 90.36% | 88.22% | 91.04% | 93.63% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.98B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
32.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 32.21% |
| 2026-03-31 | 31.87% |
| 2025-12-31 | 33.13% |
| 2025-09-30 | 32.21% |
| 2025-06-30 | 32.59% |
| 2025-03-31 | 31.88% |
| 2024-12-31 | 34.15% |
| 2024-09-30 | 31.82% |
| 2024-06-30 | 32.47% |
| 2024-03-31 | 31.41% |
| 2023-12-31 | 33.44% |
| 2023-09-30 | 32.04% |
| 2023-06-30 | 31.66% |
| 2023-03-31 | 31.17% |
| 2022-12-31 | 31.88% |
| 2022-09-30 | 31.26% |
| 2022-06-30 | 31.91% |
| 2022-03-31 | 30.97% |
| 2021-12-31 | 32.40% |
| 2021-09-30 | 30.94% |
| 2021-06-30 | 31.58% |
| 2021-03-31 | 29.81% |
| 2020-12-31 | 30.16% |
| 2020-09-30 | 29.02% |
| 2020-06-30 | 29.80% |
| 2020-03-31 | 29.35% |
| 2019-12-31 | 29.05% |
| 2019-09-30 | 27.08% |
| 2019-06-30 | 27.04% |
| 2019-03-31 | 26.98% |
| 2018-12-31 | 27.46% |
| 2018-09-30 | 26.67% |
| 2018-06-30 | 27.22% |
| 2018-03-31 | 25.50% |
| 2017-12-31 | 27.43% |
| 2017-09-30 | 26.75% |
| 2017-06-30 | 27.53% |
| 2017-03-31 | 26.89% |
| 2016-12-31 | 27.65% |
| 2016-09-30 | 26.50% |
| 2016-06-30 | 25.46% |
| 2016-03-31 | 26.26% |
| 2015-12-31 | 26.18% |
| 2015-09-30 | 27.89% |
| 2015-06-30 | 27.60% |
| 2015-03-31 | 26.77% |
| 2014-12-31 | 27.41% |
| 2014-09-30 | 26.75% |
| 2014-06-30 | 26.02% |
| 2014-03-31 | 26.04% |
| 2013-12-31 | 25.90% |
| 2013-09-30 | 25.59% |
| 2013-06-30 | 25.26% |
| 2013-03-31 | 25.08% |
| 2012-12-31 | 27.50% |
| 2012-09-30 | 28.62% |
| 2012-06-30 | 29.05% |
| 2012-03-31 | 27.44% |
| 2011-12-31 | 31.51% |
| 2011-09-30 | 30.28% |
| 2011-06-30 | 29.46% |
| 2011-03-31 | 28.51% |
| 2010-12-31 | 30.22% |
| 2010-09-30 | 28.83% |
| 2010-06-30 | 29.38% |
| 2010-03-31 | 29.13% |
| 2009-12-31 | 29.82% |
| 2009-09-30 | 29.42% |
| 2009-06-30 | 29.60% |
| 2009-03-31 | 29.33% |
| 2008-12-31 | 30.38% |
| 2008-09-30 | 28.49% |
